Journal for ImmunoTherapy of Cancer

Comprehensive multiplexed autoantibody profiling of patients with advanced urothelial cancer
Praful Ravi, Dory Freeman, Jonathan Thomas, Arvind Ravi, Charlene Mantia, Bradley A McGregor, Jacob E Berchuck, Ilana Epstein, Petra Budde, Behnaz Ahangarian Abhari, Elena Rupieper, Jana Gajewski, Ann-Sophie Schubert, Annika L Kilian, Manuel Bräutigam, Hans-Dieter Zucht, Guru Sonpavde

Journal for ImmunoTherapy of Cancer Feb 2024, 12 (2) e008215; DOI: 10.1136/jitc-2023-008215
Gamma delta T cells in acute myeloid leukemia: biology and emerging therapeutic strategies
Adishwar Rao, Akriti Agrawal, Gautam Borthakur, Venkata Lokesh Battula, Abhishek Maiti

Journal for ImmunoTherapy of Cancer Feb 2024, 12 (2) e007981; DOI: 10.1136/jitc-2023-007981
Phase 1/2 study of monalizumab plus durvalumab in patients with advanced solid tumors
Sandip P Patel, Teresa Alonso-Gordoa, Susana Banerjee, Ding Wang, Jarushka Naidoo, Nathan E Standifer, Doug C Palmer, Lin-Yang Cheng, Panagiotis Kourtesis, Maria L Ascierto, Mayukh Das, Jennifer R Diamond, Matthew D Hellmann, Benedito A Carneiro

Journal for ImmunoTherapy of Cancer Feb 2024, 12 (2) e007340; DOI: 10.1136/jitc-2023-007340
TGFβ-specific T cells induced by a TGFβ-derived immune modulatory vaccine both directly and indirectly modulate the phenotype of tumor-associated macrophages and fibroblasts
Maria Perez-Penco, Lucia Lara de la Torre, Inés Lecoq, Evelina Martinenaite, Mads Hald Andersen

Journal for ImmunoTherapy of Cancer Feb 2024, 12 (2) e008405; DOI: 10.1136/jitc-2023-008405
Harmonization of tumor mutation burden testing with comprehensive genomic profiling assays: an IQN Path initiative
Riziero Esposito Abate, Raffaella Pasquale, Alessandra Sacco, Vittorio Simeon, Monica Rosaria Maiello, Daniela Frezzetti, Paolo Chiodini, Nicola Normanno

Journal for ImmunoTherapy of Cancer Feb 2024, 12 (2) e007800; DOI: 10.1136/jitc-2023-007800
CAR-mediated targeting of NK cells overcomes tumor immune escape caused by ICAM-1 downregulation
Jiri Eitler, Wiebke Rackwitz, Natalie Wotschel, Venugopal Gudipati, Nivedha Murali Shankar, Anastasia Sidorenkova, Johannes B Huppa, Paola Ortiz-Montero, Corinna Opitz, Stephan R Künzel, Susanne Michen, Achim Temme, Liliana Rodrigues Loureiro, Anja Feldmann, Michael Bachmann, Laurent Boissel, Hans Klingemann, Winfried S Wels, Torsten Tonn

Journal for ImmunoTherapy of Cancer Feb 2024, 12 (2) e008155; DOI: 10.1136/jitc-2023-008155
Metastatic gastric cancer target lesion complete response with Claudin18.2-CAR T cells
Gregory P Botta, Joseph Chao, Hong Ma, Michael Hahn, Gloria Sierra, Jie Jia, Amanda Y Hendrix, Joy V Nolte Fong, Audrey Ween, Peter Vu, Aaron Miller, Michael Choi, Benjamin Heyman, Gregory A Daniels, Dan Kaufman, Catriona Jamieson, Zonghai Li, Ezra Cohen

Journal for ImmunoTherapy of Cancer Feb 2024, 12 (2) e007927; DOI: 10.1136/jitc-2023-007927
Paired single-B-cell transcriptomics and receptor sequencing reveal activation states and clonal signatures that characterize B cells in acute myeloid leukemia
Shengnan Guo, Gopi S Mohan, Bofei Wang, Tianhao Li, Naval Daver, Yuting Zhao, Patrick K Reville, Dapeng Hao, Hussein A Abbas

Journal for ImmunoTherapy of Cancer Feb 2024, 12 (2) e008318; DOI: 10.1136/jitc-2023-008318
Nivolumab monotherapy or combination with ipilimumab with or without cobimetinib in previously treated patients with pancreatic adenocarcinoma (CheckMate 032)
Margaret Callahan, Asim Amin, Frederic J Kaye, Michael A Morse, Matthew H Taylor, Katriina J Peltola, Padmanee Sharma, Eileen M O'Reilly, Stephanie Meadows Shropshire, Shaun O'Brien, Marina Tschaika, Dung T Le

Journal for ImmunoTherapy of Cancer Feb 2024, 12 (2) e007883; DOI: 10.1136/jitc-2023-007883
Systemically administered low-affinity HER2 CAR T cells mediate antitumor efficacy without toxicity
Tamer Basel Shabaneh, Andrew R Stevens, Sylvia M Stull, Kristen R Shimp, Brandon W Seaton, Ekram A Gad, Carla A Jaeger-Ruckstuhl, Sylvain Simon, Amanda L Koehne, Jason P Price, James M Olson, Benjamin G Hoffstrom, David Jellyman, Stanley R Riddell

Journal for ImmunoTherapy of Cancer Feb 2024, 12 (2) e008566; DOI: 10.1136/jitc-2023-008566

Main menu

Journal for ImmunoTherapy of Cancer

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Journal for ImmunoTherapy of Cancer

Pages